AcuityMD raises $80m for AI augmentation to medtech sales platform

AcuityMD has raised $80m to beforehand its proviso for assisting medtech companies successful accelerating the adoption of their products crossed healthcare settings and geographic markets.

The Boston-based company’s Series C financing circular was led by existing capitalist StepStone Group. VC firms Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management besides participated.

Used by 16 of the apical 20 medtech companies, AcuityMD’s level identifies metrics including physicians, facilities, networks, procedures, and reimbursement dynamics. Aggregating this information alongside medtech companies’ interior data, including contracting information, merchandise indications, territory structure, and CRM activity, companies tin amended estimation commercialized execution and scope the close extremity markets for their products.

With the caller backing successful hand, which brings AcuityMD’s full backing to day to implicit $160m, the institution plans to augment its existing level with artificial quality (AI) with the motorboat of AcuityAI. According to the AcuityMD, its AI platform’s wide purpose is to avail medtech institution income representatives with much streamlined insights.

As good arsenic advancing its AI capabilities, AcuityMD besides intends to usage the backing towards deepening the medtech ontology of it information model, and to grow the level beyond commercialized pursuits, with a presumption to accelerating adoption crossed the afloat merchandise lifecycle.

AcuityMD CEO, Mike Monovoukas, commented: “AI volition alteration medtech, but lone with the close context, profoundly embedded successful the workflows wherever decisions are made. AcuityMD is that discourse layer, serving the rep successful the field, the commercialized person readying territories, and the teams launching the adjacent procreation of innovation.”

AI is having an appreciable interaction connected driving efficiencies successful the broader healthcare space. According to a study by GlobalData, the combined AI marketplace crossed healthcare was valued astatine $11.9bn successful 2024 and is expected to scope a valuation of $57.4bn successful 2029.

AI has emerged arsenic a constituent portion of the UK Labour Government’s 10-year program for reforming the National Health Service (NHS). Meanwhile, connected 20 April Boehringer Ingelheim opened an AI and instrumentality learning (ML) innovation centre successful London’s King’s Cross, with the purpose to harness the technologies to thrust cause find and probe to amended diligent outcomes.

"AcuityMD raises $80m for AI augmentation to medtech income platform" was primitively created and published by Medical Device Network, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.